Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Perspective Therapeutics (CATX) Shares Outstanding (Weighted Average) (2016 - 2026)

Perspective Therapeutics' Shares Outstanding (Weighted Average) history spans 17 years, with the latest figure at $103.6 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 43.18% to $103.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $103.6 million, a 43.18% increase, with the full-year FY2025 number at $73.8 million, up 17652.94% from a year prior.
  • Shares Outstanding (Weighted Average) hit $103.6 million in Q1 2026 for Perspective Therapeutics, up from $73.8 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for CATX hit a ceiling of $228.6 million in Q1 2023 and a floor of $264573.0 in Q4 2022.
  • Historically, Shares Outstanding (Weighted Average) has averaged $75.6 million across 5 years, with a median of $72.4 million in 2025.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): crashed 99.81% in 2022 and later skyrocketed 17652.94% in 2025.
  • Tracing CATX's Shares Outstanding (Weighted Average) over 5 years: stood at $264573.0 in 2022, then skyrocketed by 117.73% to $576063.0 in 2023, then decreased by 27.82% to $415779.0 in 2024, then skyrocketed by 17652.94% to $73.8 million in 2025, then soared by 40.36% to $103.6 million in 2026.
  • Business Quant data shows Shares Outstanding (Weighted Average) for CATX at $103.6 million in Q1 2026, $73.8 million in Q4 2025, and $74.3 million in Q3 2025.